Nassim Usman - Aug 31, 2023 Form 4 Insider Report for CATALYST BIOSCIENCES, INC. (CBIO)

Signature
/s/ Seline Miller, as attorney-in-fact for Nassim Usman
Stock symbol
CBIO
Transactions as of
Aug 31, 2023
Transactions value $
$0
Form type
4
Date filed
9/1/2023, 04:07 PM
Previous filing
Aug 10, 2022
Next filing
Nov 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CBIO Series Y Preferred Stock Disposed to Issuer -24.5 -100% 0 Aug 31, 2023 Direct F1, F2
transaction CBIO Series Y Preferred Stock Disposed to Issuer -8.46 -99.95% 0 Aug 31, 2023 By The Usman Family Trust F1, F2
transaction CBIO Series Y Preferred Stock Disposed to Issuer -1.17 -99.83% 0 Aug 31, 2023 By Nassim Usman IRA F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 20, 2023, the Company's board of directors (the "Board") declared a dividend of one one-thousandth of a share of Series Y Preferred Stock, par value $0.001 per share (the "Preferred Stock"), for each outstanding share of common stock to common stockholders of record at 5:00 p.m. Eastern Time on June 30, 2023, in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on June 30, 2023. As a result, the Reporting Person received the shares of Preferred Stock set forth above. The Preferred Stock was not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company.
F2 On August 31, 2023, the Company filed, as approved by the Board, a certificate of elimination with the Secretary of State of the State of Delaware pursuant to which the outstanding shares of the Preferred Stock were eliminated.